What do coagulation tests (Coags) assess?

• A. Risk for thrombosis
• B. Risk for bleeding
• C. Electrolyte balance
• D. Liver enzyme levels

Answer: (B)

Coagulation tests, often referred to as "coags," primarily assess the blood's ability to clot, which provides vital information about the risk for bleeding. These tests measure various factors in the coagulation pathway, including prothrombin time (PT), activated partial thromboplastin time (aPTT), and platelet function. A prolonged PT or aPTT can indicate a deficiency in clotting factors or platelet dysfunction, which increases the risk of spontaneous bleeding or excessive bleeding after an injury.

While coagulopathy can also relate to thrombosis, which is related to excessive clotting, the primary focus of routine coagulation tests is to identify patients who may be at risk of bleeding complications. This is crucial for managing patients undergoing surgery, those on anticoagulant therapy, or those with liver disease, where clotting factor production may be impaired.

The other options relate to different aspects of health assessment: thrombotic risk is more associated with conditions like venous thromboembolism and not directly evaluated by routine coags, electrolyte balance is typically assessed through metabolic panels, and liver enzyme levels are specifically tested to evaluate liver function and injury, not coagulation status.